AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31597591
Drug: Support package
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Support package including a website, printed booklet, and cognitive-behavioral therapy-based sessions delivered by a qualified practitioner
Trial: 28623947
Drug: digital automated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: digital automated CBT‐I delivered by a web and/or mobile platform (in addition to treatment as usual (TAU))
Trial: 27575673
Drug: Inhalation aromatherapy
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation aromatherapy
Trial: 21277704
Drug: Standard Clinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Clinic Treatment (ST)
Trial: 16483155
Drug: Sperm concentration
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sperm concentration > 20 x 10(6)/ml
Trial: 25520332
Drug: Micafungin 100
RxNorm normalized name: micafungin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin 100 mg
Trial: 1385919
Drug: Bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine with morphine (group B)
Trial: 6741887
Drug: Rehearsal preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehearsal preparation procedure
Trial: 6741887
Drug: Usual preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual preparation (Control)
Trial: 21135531
Drug: Nonpharmacological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpharmacological therapy (holistic cognitive rehabilitation program)
Trial: 19799537
Drug: β-blockers (premedication)
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blockers (premedication)
Trial: 11822997
Drug: Mirtazapine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (15 mg at bedtime, titrated to 30 mg if needed)
Trial: 7723155
Drug: Aggressive medical
RxNorm normalized name: ZO SKIN HEALTH Aggressive Anti-Aging Program KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive medical management (daily aspirin and risk factor management)
Trial: 6458577
Drug: 0.5% topical
RxNorm normalized name: Carac 0.5% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% topical thymoxamine hydrochloride
Trial: 28473213
Drug: Topical ice
RxNorm normalized name: Camphor Ice Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ice slush cooling
Trial: 21838789
Drug: BAY 60‐5521
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 60‐5521 (25 mg)
Trial: 21838789
Drug: BAY 60‐5521
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 60‐5521 (50 mg)
Trial: 21838789
Drug: BAY 60‐5521
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 60‐5521 (all doses)
Trial: 10493456
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ipriflavone daily for 12 months
Trial: 10493456
Drug: 1 microg
RxNorm normalized name: Alpha 1 microglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 microg vitamin D3 daily for 12 months
Trial: 8672854
Drug: Taxotere (docetaxel)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Taxotere (docetaxel) at 100 mg/m2 administered in 1 hour perfusion every 21 days
Trial: 8672854
Drug: CPT 11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT 11 (irinotecan) at 350 mg/m2 every three weeks
Trial: 8672854
Drug: CPT 11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT 11 (irinotecan) at 500 mg/m2 with drug support against diarrhea
Trial: 1838693
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg cilazapril
Trial: 6635104
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg hydrochlorothiazide + 5 mg amiloride (control group)
Trial: 19160103
Drug: Oral brush
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral brush biopsy (OralCDx)
Trial: 17174102
Drug: Disulfiram (DIS)
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram (DIS) 400mg daily + Cognitive Behaviour Therapy (CBT)
Trial: 11786588
Drug: 1-hour infusion
RxNorm normalized name: coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT [Alprolix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-hour infusion of paclitaxel 100 mg/m2
Trial: 3289947
Drug: felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 5 mg b.i.d. in addition to HCTZ 25 mg o.m.
Trial: 3289947
Drug: propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol 80 mg b.i.d. in addition to HCTZ 25 mg o.m.
Trial: 24045883
Drug: Modafinil (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (300 mg/d)
Trial: 19716589
Drug: Sperm treatment
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sperm treatment with exogenous platelet-activating factor (PAF)
Trial: 19716589
Drug: No sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No sperm treatment with exogenous platelet-activating factor (PAF)
Trial: 15612842
Drug: Couples alcohol‐focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Couples alcohol‐focused treatment
Trial: 15671806
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of azithromycin
Trial: 9269606
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of ciprofloxacin
Trial: 8324868
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg intravenous ondansetron
Trial: 8324868
Drug: 0.30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.30 mg/kg intravenous ondansetron
Trial: 8324868
Drug: 0.015 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.015 mg/kg intravenous ondansetron
Trial: 23419735
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin therapy (Control)
Trial: 24785989
Drug: Solifenacin 5
RxNorm normalized name: solifenacin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 5 mg, 6 hours before surgery and 5 mg per day after surgery for 2 weeks
Trial: 21501692
Drug: CIC‐HFA 148
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIC‐HFA 148 μg
Trial: 15238279
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg copper/L
Trial: 15238279
Drug: > 6
RxNorm normalized name: {70 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit > 69.5 KG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: > 6 mg copper/L
Trial: 15238279
Drug: < 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: < 0.01 mg copper/L (control)
Trial: 2689970
Drug: Ventilatory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventilatory muscle endurance training (breathing through an inspiratory resistor equivalent to 85% SIP for 15 minutes twice daily, 5 days a week for 8 weeks)
Trial: 31405532
Drug: Stretching regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stretching regimen (three daily exercises to stretch the calves and hamstrings)
Trial: 9476695
Drug: Caffeine (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (0, 50, or 100 mg per hour for 5 hours, total of 0, 250, or 500 mg)
Trial: 7885978
Drug: Ampicillin-sulbactam 3
RxNorm normalized name: ampicillin / sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam 3 g
Trial: 2745258
Drug: Cefoxitin 2
RxNorm normalized name: cefoxitin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin 2 g
Trial: 16929626
Drug: Deaf individuals
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deaf individuals (bilingual, nasal-breathing, bilingual, buccal-breathing, oralist, nasal-breathing)
Trial: 11153591
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g alcohol x kg body weight consumed 90 min prior to sleep time
Trial: 2442552
Drug: Lisinopril (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (20-80 mg/day)
Trial: 11349617
Drug: Nifedipine (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40-80 mg/day)
Trial: 31600823
Drug: Potentially misclassified
RxNorm normalized name: Potentilla discolor whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potentially misclassified intrapartum stillbirths (180) with birthweight less than 2500 g.
Trial: 18928092
Drug: Suhuang Zhike
RxNorm normalized name: MENTHOL 4.3 g / METHYL SALICYLATE 9.4 g TOPICAL OIL [Shuang Long Pain Relieving Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suhuang Zhike Capsule (SZC), 3 capsules three times daily for 7 days
Trial: 18928092
Drug: Zhike Ningsuo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhike Ningsuo Capsule (ZNC), 3 capsules three times daily for 7 days
Trial: 12736566
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B (FT + TAM 20 mg/day for 2 years)
Trial: 8969280
Drug: Diet B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet B (50 g protein/d)
Trial: 1482268
Drug: verapamil 240
RxNorm normalized name: verapamil 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 240 mg SR (V)
Trial: 1482268
Drug: nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine 20 mg SR (N)
Trial: 4006378
Drug: Oral pseudoracemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pseudoracemic verapamil (160 mg)
Trial: 27724916
Drug: Robot-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted therapy
Trial: 27978944
Drug: Upstream antithrombotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upstream antithrombotic treatment
Trial: 20693157
Drug: Lifibrol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifibrol (600 mg/d)
Trial: 11742880
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg/d)
Trial: 10582873
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of azithromycin daily for 6 weeks
Trial: 10582873
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg of azithromycin daily for 6 weeks
Trial: 1831017
Drug: 75 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 micrograms of intravenous fentanyl intraoperatively
Trial: 6120763
Drug: Lorazepam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (4 to 10 mg IV)
Trial: 6120763
Drug: Clonazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (1 mg IV)
Trial: 17631800
Drug: Yiqi Tongmai
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yiqi Tongmai Oral Liquid (YQTM)
Trial: 17631800
Drug: Shuxin Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shuxin Oral Liquid (SX)
Trial: 15675261
Drug: Both anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both anesthetic solutions
Trial: 17994292
Drug: alpha-tocopherol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-tocopherol (50 mg/day)
Trial: 17994292
Drug: beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-carotene (20 mg/day)
Trial: 9579716
Drug: roxithromycin 300
RxNorm normalized name: roxithromycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin 300 mg po od
Trial: 9579716
Drug: clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clarithromycin 500 mg po bd
Trial: 2650586
Drug: Clemastine tablet
RxNorm normalized name: clemastine Oral Tablet
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine tablet
Trial: 28695477
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of xylometazoline and dexpanthenol
Trial: 28695477
Drug: Xylometazoline monotherapy
RxNorm normalized name: XYLOMETAZOLINE
DrugBank: Xylometazoline (DB06694)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylometazoline monotherapy
Trial: 21679262
Drug: HCV treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV treatment eligibility
Trial: 12131885
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water irrigation with One-Step bonding agent
Trial: 12131885
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl irrigation with One-Step bonding agent
Trial: 12131885
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline irrigation with One-Step bonding agent
Trial: 12131885
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline irrigation with Solo bonding agent
Trial: 29396219
Drug: Nutrition intervention
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition intervention (counselling on appropriate maternal, infant, and young child feeding plus small-quantity lipid-based nutrient supplements from 6-24 months)
Trial: 8534483
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) 500 micrograms twice daily for 4 months
Trial: 1810682
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg sublingually after 1 hour of nitroglycerin (3 mg/h) and heparin (1200 IU/h) infusion
Trial: 30633040
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral tablet
Trial: 3306290
Drug: Org OD
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org OD 14 (2.5 mg/day)
Trial: 22348981
Drug: Coated implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coated implants with a thin fibrinogen layer containing 2 bisphosphonates
Trial: 22348981
Drug: Untreated implants
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated implants
Trial: 18265662
Drug: Lamivudine monotherapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine monotherapy after combination therapy
Trial: 18265662
Drug: Long-term antiviral
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antiviral maintenance therapy
Trial: 11196521
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate (CS) 1 g/day
Trial: 2816360
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) treatment for 6 months
Trial: 1215880
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in males
Trial: 1215880
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in females
Trial: 1215880
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in patients under 60 years
Trial: 1215880
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in patients with predisposing factors
Trial: 31390762
Drug: Combined synbiotics
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined synbiotics and BCAAs treatment
Trial: 23507791
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg triamcinolone acetonide (low-dose group, n = 20)
Trial: 21499192
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of bevacizumab (1.25 mg) 1 week before vitrectomy
Trial: 19335800
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg lidocaine hydrochloride 10% spray
Trial: 1914480
Drug: Selective parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective parenteral and enteral antisepsis regimen (oral nonabsorbable antimicrobial agents: polymyxin E, gentamicin, and amphotericin B; parenteral cefotaxime)
Trial: 19649577
Drug: Skeletal anchorage
RxNorm normalized name: Spongia officinalis skeleton extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skeletal anchorage via mini-implants in the anterior palate
Trial: 17301557
Drug: TMC114/r 600/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC114/r 600/100 mg twice daily
Trial: 7880228
Drug: Atovaquone (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atovaquone (750 mg orally with meals three times daily for 21 days)
Trial: 8588062
Drug: Serotonin reuptake
RxNorm normalized name: Selective serotonin reuptake inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin reuptake inhibitors
Trial: 12668373
Drug: Other antidepressants
RxNorm normalized name: Other antidepressants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antidepressants
Trial: 17086007
Drug: Pharmaceutical agents
RxNorm normalized name: PHARMACEUTICAL GLAZE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical agents for chronic disease management
Trial: 17086007
Drug: COX-2 anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COX-2 anti-inflammatory drugs
Trial: 11061574
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg per day for 9 days)
Trial: 3709018
Drug: Albuterol aerosol
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol aerosol (180 mcg, 2 puffs) followed by hourly albuterol aerosol for 5 hours (10 puffs = 900 mcg)
Trial: 20442540
Drug: Aprotinin 20,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin 20,000 KIU/kg after induction, 20,000 KIU/kg added to pump prime, 20,000 KIU/kg/hour infusion for three hours
Trial: 15876900
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 mg twice daily)
Trial: 12600228
Drug: Imatinib 400
RxNorm normalized name: imatinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 400 or 600mg once daily
Trial: 31983019
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy-Enhanced (CBT-E)
Trial: 29630438
Drug: RTS,S/AS01 malaria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 malaria vaccine co-administered with PHiD-CV and HRV
Trial: 29630438
Drug: RTS,S/AS01 co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 co-administered with PHiD-CV
Trial: 29630438
Drug: RTS,S/AS01 co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 co-administered with HRV
Trial: 29630438
Drug: RTS,S/AS01 co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 co-administered with aP antigens
Trial: 29630438
Drug: PHiD-CV co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHiD-CV co-administered with RTS,S/AS01
Trial: 29630438
Drug: RTS,S/AS01 co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 co-administered with pediatric vaccines
Trial: 29630438
Drug: RTS,S/AS01 and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 and co-administered PHiD-CV, pertussis antigens and HRV
Trial: 29630438
Drug: HBV (Engerix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBV (Engerix B) vaccine
Trial: 25502179
Drug: CERA administered
RxNorm normalized name: CERA
DrugBank: Methoxy polyethylene glycol-epoetin beta (DB09107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CERA administered every two weeks (Q2W)
Trial: 23301484
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 50 mg dolantin injection followed by oocyte retrieval after 30 min
Trial: 20350923
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D treatment (group D)
Trial: 11190415
Drug: Fluconazole for
RxNorm normalized name: Fluconazole for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole for antifungal prophylaxis in patients with prolonged neutropenia
Trial: 11190415
Drug: Intravenous amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amphotericin B at a daily dose of 0.6 to 1 mg/kg